An integrated population pharmacokinetic model of febuxostat in pediatric patients with hyperuricemia including gout and adult population of healthy subjects and patients with renal dysfunction
Abstract The study objective was to validate febuxostat dosage and administration in pediatric patients with hyperuricemia including gout, using an integrated population pharmacokinetic (PopPK) analysis in the Japanese population. Integrated PopPK analysis of febuxostat used a nonlinear mixed‐effect...
Saved in:
| Main Authors: | Ryutaro Iwama, Kimie Nishida, Daisuke Ishii, Takeshi Iijima |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | Pharmacology Research & Perspectives |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/prp2.70032 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Febuxostat in patients with hyperuricemia and gout: is the nephroprotective effect real?
by: M. S. Eliseev, et al.
Published: (2024-10-01) -
The use of febuxostat in comorbid patients with gout in real clinical practice: own data
by: E. V. Zonova, et al.
Published: (2022-06-01) -
The place of febuxostat in the treatment of gout
by: A. M. Novikova, et al.
Published: (2020-09-01) -
Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part 2: gout therapy and the gut microbiota
by: M. S. Eliseev, et al.
Published: (2022-12-01) -
Febuxostat in the therapy of gout: from theory to practice
by: E. V. Ilyinykh, et al.
Published: (2018-01-01)